-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-319 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBV-319 in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-319 in Follicular Lymphoma Drug Details: ABBV-319 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRX-012 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRX-012 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRX-012 in Alzheimer's Disease Drug Details: PRX-012 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-1070806 in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-1070806 in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-1070806 in Crohn's Disease (Regional Enteritis) Drug Details: GSK-1070806...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oleclumab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oleclumab in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Oleclumab in Solid Tumor Drug Details: Oleclumab (MEDI-9447) is under development...
-
Product Insights
NewHernia Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hernia Repair Devices Pipeline Market Report Overview Hernia Repair Device is a hernia mesh used to cure a hernia. Hernia is a condition where an organ or tissue bulges out through a weak spot in the surrounding muscle or connective tissue and can arise in a variety of locations throughout the body, including the pelvis, abdomen, and diaphragm. The hernia repair devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Sector Analysis
NewVenous Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Venous Stents Market Report Overview The Venous Stents market size was valued at $784.4 million in 2023 and will grow at a CAGR of more than 2% during 2023-2033. A venous stent is a self-expandable metallic tube with perforations. It is inserted into a vein to prevent blood flow constriction caused by obstructions and occlusions in the venous vasculature. Venous stent placement is considered in case of significant stenosis or extrinsic compression. Venous Stents Market Outlook 2023-2023 ($ Million) Buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Spesolimab in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Spesolimab in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Spesolimab in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo...
-
Product Insights
NewConforMIS Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ConforMIS Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ConforMIS Inc (ConforMIS) is a medical technology company. It manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDuo a customized bicompartmental knee replacement system. ConforMISalso provides iUni a customized unicompartmental knee replacement product, and iTotal Hip a hip replacement product...
-
Product Insights
NewOphthalmic Imaging Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Imaging Equipment Pipeline Market Report Overview Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases. The ophthalmic imaging equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Sector Analysis
NewVascular Grafts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Vascular Grafts Market Report Overview The vascular grafts market size was valued at $723.1 million in 2023 and will grow at a CAGR of more than 5% during 2023-2033. The following are some of the key highlights of the vascular grafts market: In 2023, the peripheral vascular grafts segment accounted for the highest share of the market. North American vascular grafts market share was the highest in 2023. In 2023, the W. L. Gore & Associates Inc. company led the...